Reparative techniques are vital in endodontics, andconservative measureshelp preserve the vitality of teeth and ensuring they are in good health [1,2]. Mineral trioxide aggregate(MTA) is a biocompatible compound that has found widespread usage in clinical endodontic therapy because of its low cytotoxicity and high biocompatibility and ability to stimulate new dentin development. It has been the material of paramount importance since its introduction in the 1900s [3]. Uses of MTAinclude conservative management of root fractures, perforation repair [4], pulp capping agent [5], apexification [6], retrograde filling material in apical microsurgeries [7], and revascularization measures as a coronal barrier[2]. The above procedures involve close contact with the body fluids and vital tissues, favoring physical alterations and chemical/biological communications with the material [8].
Various properties of MTA, such as physical, chemical, and biological, have been explored for extended periods, leading to discoveries of its efficient substitutes. However, improvisations are still needed to arrive at an ideal composition of the constituents of the cement. The development of a model, unflawed restorative material is still long due. To achieve thisit should possess the following characteristic properties: sealing ability, dimensional [9] and color stability [10], radio-opacity [11], insolubility when in contact with body fluids, and ability to flow with easy insertion. It should also possess biological and chemical properties such as alkaline pH, calcium (Ca) ion release, bioactivity, cell attachment, and biocompatibility[12]. Mineral trioxide aggregate owns most of the mentioned ideal properties but lacks a few, primarily color and consistency which require the most improvisations[13]. Therefore, materials with newer innovations have been launched commercially to overcome these shortcomings. This review intends to highlight the properties of MTAwith their limitations and to arrive at the developments in innovative Ca silicate-based cements (CSCs).
The main emphasis should be on the clinical facet of these CSCs, as the site of placement directly influences and determines materialproperties[14]. Mineral trioxide aggregateis a dynamic, active material as its application and placement result in constant contact of the cement with tissues and fluids. It persists for years after its insertion[15]. Its mechanism comprises Ca hydroxide leaching out of the hydrated MTA, thereby highlighting the bioactivity of MTA, which relates to the calcium ion(Ca2+) release. Placement of MTAis usually required at the site where there is a presence of blood that contaminates it, affecting the structure of the set material and reducing the Ca2+ release[6,16]. The principal limitations of MTA include a delayed setting time, lack of good handling features, and the disadvantage of discoloration.
Also, the contact of MTAwith blood can alter the color of the material andinterferes with radiopacity over time[17]. Moisture drastically affects the time of setting and the material solubility. Excessive water results in increased solubility and setting time of MTA. During the setting process of MTA, it chemically interacts with tissues making the environment alkaline by releasing Ca2+ ions, which are linked to the development of portlandite (calcium hydroxide) by tricalcium silicate (C3S) and dicalcium silicate (C2S)[18].
In vitro studies done with MTAAngelus and ProRoot MTArevealed Ca2+ ion discharge andalkalization of the environment when the material was submerged in water. The release of Ca2+ ions was detected by von Kossa staining of subcutaneous tissues of rats[19]. These properties lead to mineralization on the surface of the set MTAin pulpotomy procedures. This is proven by studies where hard tissue was formed apically in a dog's teeth which were seen along with the sealing ability in cases of furcation perforation[20].
In an in vivo study by Han et al., the odontogenic potential of osteostatin (OST) and the combined effect with bioceramic materials on human dental pulp stem cells (hDPCs) were investigated, and it was discovered that the combination of MTAand OSThad a synergistic odontogenic differentiation of hDPCs when compared to MTAalone[21]. Micro-CT research demonstrated that OSTwith ProRoot MTAgroups formed more mineralized dentin bridges[22].
During dental operations, the most significant property of observation is color. Tooth discoloration damages the tooth's aesthetic appearance. The complex response between filling materials and coronal dentine of the pulp chamber, which modifies the crowns appearance, is a significant cause of tooth discoloration.
Initially, when developed, MTAhad a grey color owing to the presence of tetra Ca aluminoferrite, making it unsuitable for its application on anterior teeth. Therefore, this led to the establishment of white MTA which is devoid of iron to prevent the discoloration of the tooth. On the contrary, many studies have proven the alteration in color even with white MTA[23]. The composition of white MTAincludes C2S and C3S silicate with 20% of bismuth oxide. According to reports, the amount of bismuth oxide added to MTA to increase its radio-opacity was only 8.4% in the set material compared to 21.6% in the unset material [8]. When reduction of bismuth oxide occurs along with its contact with the tooth structure, it alters the color of the cement and the color of the adjacent tooth structure. The cause of color change has been identified and attributed to the loss of stability of the bismuth oxide molecules, which occurs as they come in close contact with a potent oxidizing agent[24]. Hence, it is suggested that if the radiopacifier agent is changed, it can help prevent the discoloration of the tooth. Two materials have been lab tested to replace bismuth oxide, namely zirconium oxide and Ca tungstate. However, large amounts are necessary to match the radiopacity ofbismuth oxide. Adding such large amounts can negatively impact the chemical and physical properties of the dental material[25]. Newer CSCs such as Biodentine and Bioceramic (BC) sealer, and MTA high plasticity (HP) can alter the radiopacifier agent into Ca tungstate or zirconium oxide.These constituents caused no alteration in color[26]. The second substitute is the addition of 5% zinc oxide (ZnO) to MTAas this ZnO converts bismuth oxide into bismite, a product that helps prevent the change of color[10].
There is a difference in opinion regarding the consistency of MTA. The ratio of powder to water is essential as increasing the quantity of water reduces radiopacity. The particle size is vital here as the newer advances in silicate types of cement have been developed using nanoparticles of Ca silicate (CS). The BCsealer and biosealer containing nanoparticles of CSwith the addition of a polymer help in easy handling and givean ideal material consistency. Adding propylene glycol to MTAcaused no interference in its biological properties. Propylene glycol was tested using different ratios for chemical and physical properties in which 20% propylene glycol was mixed with 80% distilled H2O,which led to efficient handling of MTA, pH, enhanced Ca release, and flowability. However, it caused slight alterations in setting time[27]. Few studies have proven that propylene glycol caused improved adhesion of MTA.
The advances which lead to enhanced flow ability comprise MTA HP, MTA Flow, Biodentine (Septodont, Saint-Maur-des-Fosss, France),and ones having ceramic complexes incorporated with Biodentine, EndoSequence (Brasseler, Savannah, GA, USA), and BioAggregate (Verio Dental Co. Ltd., Vancouver, Canada).
In 2009, Biodentine, a Ca silicate-based product, was introduced. Zirconium oxide is used instead of bismuth oxide in Biodentine. Zirconium oxide is a bioinert substance with good mechanical qualities & corrosion resistance. Dettwiler et al. 2016 observed this closely in an experiment [28]. Biodentine had a minor discoloration, higher solubility than MTA, and a significantly faster setting time. In as little as 12 minutes, Biodentine can begin to block blood components, becoming denser and packed as it sets. As a result, erythrocyte penetration is reduced, resulting in less tooth discoloration during the pulpotomy operation. Because it comprises more powder with a water-reducing agent and less porosity, the Biodentine material significantly impacts various factors such as absorption, strength, and density[29]. Biodentine and zinc oxide-eugenolcement (IRM) had the lowest level or degree of porosity and the least amount of tooth discoloration, according to Camilleri et al. in 2013[14].
Endosequence root repair material (ERRM), is available as a premixed putty with uniform consistency and easier handling and application. According to the manufacturer, the setting begins with the presence of moisture in the dentinal tubules. When pulp cells were exposed to ERRMor ProRoot MTA, survival and proliferation were identical, suggesting that it could be a good choice for pulp capping treatments[30].
BioAggregate (BA)contains monobasic Ca phosphate, amorphous silicon dioxide, and tantalum pentoxide for radiopacity. And due to its Ca phosphate content,it is classified as a biphasic material (one that contains two cementitious ingredients)[31]. It is more acid resistant than MTA, has a longer-lasting strengthening effect on weaker teeth, and has a lower risk of discoloration[31]. In the treatment of immature teeth, it has demonstrated similar results as MTA.
The main composition of MTAis CS. Bioactivity is one characteristic feature of Ca silicate-based types of cement[27]. Newer CS-based restorative types of cement have been launched to substitute bismuth oxide like Biodentine, Neo MTAPlus (Avalon Biomed Inc.Bradenton, FL, USA), and MTARepair HP (Angelus, Londrina, PR, Brazil). Others include MTAFillapex (Angelus, Londrina, PR, Brazil), Neo MTAPlus, iRoot SP (Innovative BioCreamix Inc, Vancouver, BC, Canada), and TotalFill BC (Davis Schottlander & Davis Ltd. Letchworth, Herts, UK) sealer.
The MTAFillapex cement comes in a paste-paste form which comprises salicylate and natural resin, infused silica nanoparticles, MTA, and Ca tungstate which acts as radiopacifier.There is a newly introduced C2S silicate-based system with a powder-gel formulation named Neo MTA, a remarkable restorative and endodontic cement that can be used with various proportions of powder gel ratios. The composition of iRoot SPis zirconium oxide, CS, Ca phosphate, Ca hydroxide, and thickening agents, which are commercially accessible and is used as a root canal filling material. On the other hand, EndoSequence BC sealer and TotalFill BC sealer comprises zirconium oxide, CS, monobasic Caphosphate, Ca hydroxide, and thickening agents. This latter cement is advantageous as it sets in the presence of dentin moisture and hence was used as canal filling material.
A study on iRoot SPendodontic cement advocated the absence of cytotoxicity to fibroblasts when tested in rats[32]. Alternative research by Zoufan et al., checked the cell compatibility of iRoot SPcement at two stages: after the cement was freshly mixed, and after the cement had been set[33]. It was found that this cement had a greater induction capacity of osteoblastic differentiation and decreased inflammatory response with the periodontal ligament cells compared to Sealapex[34].
The MTAand iRoot SPtypes of cement have been proven to induce differentiation in osteoblastic cells in the tooth germ. The iRoot SPsignificantly showed its antibacterial activity against Enterococcus faecalis[35]. Zhu et al. found evidence of the ability of BioAggregate cement to promote cell adhesion to each other, migration, and fixation of human dental pulp cells, thus proving its cytocompatibility[36].
Bioceramic endodontic cement-like Endosequence BC sealerhas displayed promoting superior cell viability than AHPlus sealer and also offered an increased level of biocompatibility when compared with newly handled AHPlus and MTAFillapex,when freshly mixed and after the setting. Bioceramic sealer has shown satisfactory adhesion to fibroblasts[37]. Upon contact with the biological solution, discharge of Ca and development of the Ca phosphate phase was seen. Antibacterial activity against biofilm formed on dentin was greater when Endosequence BC sealer was used along with 5% sodium hypochlorite than the irrigation solution alone[38]. In a study using confocal laser microscopy, Wang et al. concluded that in 30 days, a BioCeramic sealer could eliminate 45% of E. faecalis from the dentinal tubules, indicating the antibacterial action of theBioceramic sealer lasted even after the setting of the material [39]. Total fill BioCeramic sealer is identical to Endosequence BC sealer. The only difference is that the former promotes extensively higher proliferation of cells compared to AHPlus and MTA Fillapex.The structure of cells embedded on Total Fill BioCeramic Sealer and AHPlus showed similar physiognomies, along with the assembly of the extracellular matrix. In contrast, limited fixation of cells was seen on discs of MTAFillapex, with decreased number of cells on the material surface[40].
The MTA Angelus, MTA HP, and Neo MTA P presented viability of cells and a higher degree of cellular proliferation along with adhesion. Using HDPCs, greater viability was seen with MTAplus compared to MTAFillapex and Fillcanal; increased phosphates activity was observed with MTAPlus[41,42]. No cytotoxic effect was seen with Neo MTAPlus, MTAAngelus, and experimental C3S silicate-based cement with tantalum oxide (TSC/Ta205). According to the alizarin red assay, the three materials were proven to induce the formation of mineralized nodules; on the other hand, NEOproduced a considerable quantity of mineralized nodules compared to MTAand TSC[43]. Following subcutaneous implantation in rats, histological analysis established that MTA HPshowed similar biomineralization and biocompatibility potentials to MTA Angelus[43]. The MTAAngelus and MTAPlus showed no presence of cytotoxicity and induced mineralized nodule formation. When PCR was used, the authors concluded that when HDCPs were exposed to extract the two types of cement, it increased the expression of osteogenic markers of the cell[44].
According to Petrovic et al., materials based on CSand hydroxyapatite (HA-CS) showed a superior grade of biocompatibility compared to MTAAngelus [45]. Also, improved outcomes were seen for CS and HA-CS when subcutaneous implants were placed in rats. In the assessment of the biocompatibility of three Ca silicate-based types of cement, which include Bioroot BC sealer (BR), Endoseal MTA(ES) & Nanoceramic sealer (NCS), along with human periodontal ligaments stem cells (hPDLSCs), BRand NCSshowed superior cytocompatibility as compared to ES[46]. The BCsealer was proficient in hindering the release of immunoreactive calcitonin gene-related peptide (iCGRP) from trigeminal ganglion neurons and excellent biocompatibility, thereby reducing the symptomatology level after extravasation of the cement in ongoing treatment[47].
In a study by Almedia et al., a comparison of physiochemical and biological properties of already mixed Ca silicate-based endo sealers with routinely used root canal (RC) filling materials by thoroughly revising lab investigations [48]. Calcium silicate-based endodontic sealers followthe ISO 6876:2012 standard for most physicochemical properties, except solubility. The target sealers depicted commendatory biological traits in comparison to conventional sealers. Despite failing to test the target premixed Ca silicate-based sealers in long-term experimental clinical trials, they presented with good physicochemical and biological traits in vitro.
Visit link:
A Breakthrough in the Era of Calcium Silicate-Based Cements: A Critical Review - Cureus
- 4 Reasons To Save Baby Teeth And Ways To Preserve Them - MomJunction - October 6th, 2024
- Stem Cells May Help In Treatment of Tuberculosis, But Challenges Remain: Study - News18 - April 23rd, 2023
- Buccal Fat Pad as a Potential Source of Stem Cells for Bone ... - Hindawi - December 20th, 2022
- Difference Between Adult and Embryonic Stem Cells - December 20th, 2022
- Nicklas Brendborg: Keeping your mouth clean is one of the few easy things you can do to extend your life - EL PAS USA - November 17th, 2022
- Effect of Puerarin on New Bone Formation In Vivo | DDDT - Dove Medical Press - August 27th, 2022
- The Tokyo Medical and Dental University (TMDU) team succeeded with the world's first Mini Organ transplantation to a patient with Ulcerative Colitis... - August 27th, 2022
- Stem cell-based biological tooth repair and regeneration - PMC - June 26th, 2022
- Where Stem Cells Are Found, & the Difference That Makes | Cryo-Cell - June 26th, 2022
- Stem Cells International | Hindawi - June 26th, 2022
- The surprising science of breast milk - BBC - June 26th, 2022
- Plug-and-Play Human Organ-on-a-Chip Can Be Customized to the Patient - SciTechDaily - May 8th, 2022
- Twelve Rutgers Professors Named Fellows of the American Association for the Advancement of Science - Rutgers Today - January 30th, 2022
- Mouth Sores from Chemo: Symptoms, Causes, and Treatments - Healthline - February 19th, 2021
- Tooth Regeneration Market to Exhibit Steadfast Expansion by 2027 | Unilever, Ocata Therapeutics, Integra LifeSciences, CryoLife, BioMimetic... - February 14th, 2021
- Using 3D Printing to Develop Bone-Like Structures that Contain Living Cells - AZoM - February 14th, 2021
- Fear of Covid keeps patients away from dental clinics resulting in an increased need of treatment. - ETHealthworld.com - February 9th, 2021
- 3D medical printing making strides, and helping patients do the same - MedCity News - February 9th, 2021
- Global Cord Blood Banking Industry Report 2021: Industry Trends, Expansion Technologies, Profiles of Select Cord Blood Banks and Companies -... - January 14th, 2021
- Bone Therapeutics and Rigenerand sign partnership for cell therapy process development - GlobeNewswire - January 14th, 2021
- Europe Prescription Spectacles Market to Exhibit a 5.2% CAGR and Reach USD 31.89 Billion by 2027; Increasing Incidence of Ocular Disorders to Favor... - January 14th, 2021
- Priming the Immune System to Fight Cancer - PRNewswire - December 17th, 2020
- Girl gets her smile back - and a new jaw - thanks to innovative tissue engineering procedure - Newswise - December 17th, 2020
- Bone Regeneration Material Market: Cell-based Segment to Expand Significantly - BioSpace - December 17th, 2020
- Stem Cell Therapy Market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis - Cheshire Media - November 28th, 2020
- Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act - Stockhouse - November 28th, 2020
- Molecular Diagnostics Market to Record over 7% Growth Rate and Hit USD 13873.6 Million by 2025; Advancements in this Field to Increase Productivity... - November 28th, 2020
- North America Tissue Engineering Market Report 2020: Market is Expected to Reach US$12.23 Billion by 2027 from US$4.45 Billion in 2019 -... - November 22nd, 2020
- Latest Study explores the Stem Cell Banking Market Witness Highest Growth in nea - GroundAlerts.com - November 5th, 2020
- Stem Cell Therapy Market is estimated to be worth USD 8.5 Billion by 2030 - PRnews Leader - November 5th, 2020
- Canine Stem Cell Therapy Market Size, Share Analysis by Manufacturers, Regions, Type and Application to 2026 - PRnews Leader - November 5th, 2020
- Stem Cell Banking Market to witness an impressive growth during the forecast pe - News by aeresearch - November 2nd, 2020
- Global Tooth Regeneration Market: Industry Analysis and Forecast (2020-2027)-by Type, Application, Population Demographics and Region - re:Jerusalem - October 10th, 2020
- The global regenerative medicine market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9% - Yahoo... - October 10th, 2020
- The end-use Industries to Help the Tooth Regenerations market stand in a good stead between 2018 and 2026 - The Daily Chronicle - September 18th, 2020
- Increase in Frequency of Product Innovations to Drive the Tooth Regenerations Market from 2018 to 2026 - Lake Shore Gazette - September 15th, 2020
- Incremental Sales to Drive the Tooth Regenerations Market from 2018 to 2026 - Lake Shore Gazette - September 15th, 2020
- Parents plea for stem cell help to save life of daughter with rare blood disorder - Mirror Online - September 2nd, 2020
- Unraveling the use of CBD in veterinary medicine - Jill Lopez - September 2nd, 2020
- Global Stem Cell Banking Market with Covid-19 Effect Analysis, Growth, Research Findings, Type, Application, Element Global Trends and Forecast to... - September 2nd, 2020
- Plasma Therapy Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2025 - StartupNG - September 2nd, 2020
- Active Data Warehousing Market to Witness Robust Expansion Throughout the Forecast Period 2020 2025 - The Daily Chronicle - August 20th, 2020
- 3D bioprinting spatiotemporally defined patterns of growth factors to tightly control tissue regeneration - Science Advances - August 20th, 2020
- NIH names Dr. Rena D'Souza as director of the National Institute of Dental and Craniofacial Research - National Institutes of Health - August 13th, 2020
- Global Cell Theraputics Market Value Estimated To Grow With A Healthy CAGR Rate During 2020-2025: Cell Theraputics Bristol-Myers Squibb Company... - July 10th, 2020
- Global Tissue-Replacement Products Market to Witness Rapid Development During the Period 2017 2025 - Lake Shore Gazette - July 10th, 2020
- Job interviews zoom without leaving the house | What's Working - The Union Leader - July 6th, 2020
- Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute... - June 30th, 2020
- Medical Professionals in the Ozarks - 417mag - June 30th, 2020
- Dental Fitting Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty - June 10th, 2020
- Coronavirus daily news updates, June 9: What to know today about COVID-19 in the Seattle area, Washington state and the world - Seattle Times - June 10th, 2020
- Metal Fiducial Marks Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2025 - Cole of Duty - June 10th, 2020
- Impacts of COVID 19 on the Global Regenerative Medicine Market Size: Global Industry Analysis, Growth, Top Companies Revenue, MRFR Reveals Insights... - June 2nd, 2020
- Exceptional stem cell science on tap for ISSCR 2020 Virtual June 23-27, 2020 - 7thSpace Interactive - June 2nd, 2020
- Orthopedic Joint Replacement Market to Gain Traction; Rising Prevalence of Bone Diseases to Boost Growth, states Fortune Business Insights -... - June 2nd, 2020
- Coming Together to Solve COVID-19 Mysteries | University of Pennsylvania Almanac - UPENN Almanac - June 2nd, 2020
- Impact of Covid-19 on Stem Cell Banking Market 2020: Remarking Enormous Growth with Recent Trends | Cord Blood Registry (CBR) Systems (US), Cordlife... - May 27th, 2020
- Researchers develop nanoengineered bioink to 3D print functional bone tissue - 3D Printing Industry - May 27th, 2020
- Directional Osteo-Differentiation Effect of hADSCs on Nanotopographica | IJN - Dove Medical Press - May 8th, 2020
- Bone Therapeutics raises additional EUR 4.0 million, totalling EUR 15 million, providing runway into Q2 2021 - PharmiWeb.com - May 8th, 2020
- Coming together to solve the many scientific mysteries of COVID-19 - Penn: Office of University Communications - May 8th, 2020
- Bone Therapeutics secures EUR 11.0 million financing - PharmiWeb.com - April 30th, 2020
- GLOBAL TOOTH REGENERATION MARKET: INDUSTRY ANALYSIS AND FORECAST (2020-2027) - MR Invasion - April 28th, 2020
- Stromal Vascular Fraction Market to Register CAGR 4.5% Growth in Revenue During the Forecast Period 2019 to 2029 - Jewish Life News - April 28th, 2020
- UCLA scientists invent nanoparticle that could improve treatment for bone defects - UCLA Newsroom - April 27th, 2020
- Orthopedic Devices Market to Reach USD 71.67 Billion by 2026; Increasing Geriatric Population to Boost Growth, says Fortune Business Insights -... - April 10th, 2020
- A new way to study HIV's impact on the brain - Penn: Office of University Communications - March 28th, 2020
- Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer - OrthoSpineNews - March 28th, 2020
- Walking Sticks Stop, Drop and Clone to Survive - KQED - March 25th, 2020
- Hydrogel could be step forward in therapies to generate bones in head and neck - UCLA Newsroom - March 19th, 2020
- Cell Banking Outsourcing Market to Witness Surge in Demand Owing to Increasing End-use Adoption - Lake Shore Gazette - March 19th, 2020
- New evidence teeth can fill their own cavities - Big Think - March 16th, 2020
- These new stem cells have the ability to generate new bone - Tech Explorist - March 12th, 2020
- Bone Therapeutics announces 2019 full year results - OrthoSpineNews - March 12th, 2020
- Stem cells that can grow new bone discovered by researchers - Drug Target Review - March 6th, 2020
- Stem Cells that will aid new bone generation discovered as per latest research - Medical Herald - March 6th, 2020
- UConn Researchers Discover New Stem Cells That Can Generate New Bone - UConn Today - March 6th, 2020
- What's coming down the pike in the dental profession? - Dentistry IQ - February 26th, 2020
- On the Road to 3-D Printed Organs - The Scientist - February 26th, 2020
- Hyperbaric chamber therapy: Im under a lot of pressure and I love it! - The Guardian - February 26th, 2020